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Preventive strategies in bipolar disorders:
identifying targets for early intervention
Philippe Conus, Michael Berk, Nellie Lucas, José Luis Vázquez-Barquero
and Craig Macneil
Introduction
Intervention in the early phases of mental disorders has
become a major clinical and research focus and is one
of the main challenges facing contemporary mental
health. This growing interest has led to the develop-
ment of new lines of enquiry as well as the implemen-
tation of new types of treatment programme and
services. In this context, the early phase of psychosis
has attracted considerable attention in recent years; the
therapeutic strategies that have been developed as a
consequence may be beginning to improve the out-
come of these conditions (McGorry & Jackson, 1999).
Yet, most of the attention has been directed to schizo-
phrenia, probably in reaction to the pessimism tra-
ditionally associated with this disorder (Conus &
McGorry, 2002). Bipolar disorders, usually considered
with more optimism, have been relatively neglected by
this movement in comparison with schizophrenia.
However, while Kraepelin’s (1919) initial view of men-
tal illness was excessively pessimistic regarding schizo-
phrenia, it was also excessively optimistic regarding
manic depression, and the assumption of a generally
good outcome in manic depression has now been chal-
lenged many times (Conus et al., 2006a; Coryell et al.,
1993; Dion et al., 1988; Harrow et al., 1990; Tohen et al.,
1990a, 2000a,b). For the many reasons given in this
chapter, it is imperative that a preventive approach
should also be extended to bipolar disorders. Indeed,
it is likely that the key targets of early intervention in
psychosis, namely early detection and optimal, inten-
sive and sustained intervention during the early years
of illness, are relevant to bipolar disorders.
Nevertheless, much remains to be explored, and
certain basic concepts that are crucial to the develop-
ment of early intervention need clarification in the
context of bipolar disorders. In particular, while the
definition of the bipolar spectrum of disorders has
received extensive attention (Akiskal, 1999), much less
has been achieved in characterizing the various phases
leading from the onset of the initial symptoms to the
full-blown disorder. Moreover, the study of prodromal
manifestations and early phases of bipolar disorders is
particularly complex owing to some of the character-
istics of the disorder itself.
In this chapter, we review the arguments justifying
the development of early intervention in bipolar disor-
ders and then summarize knowledge gathered about
the onset of bipolar disorders. We attempt to develop a
concept that would facilitate research in this area
and provide a basis for a new treatment approach.
Importantly, it must be mentioned that ‘early interven-
tion in bipolar disorders’, the focus of this chapter, is
distinct from ‘intervention in early-onset bipolar disor-
ders’. The latter group form a controversial subset of
bipolar disorders with onsets during childhood. They
may also justify specific treatment strategies, but they
will not be discussed here.
Rationale for early intervention in bipolar
disorders
Until recently, it was considered that bipolar disorders
were characterized not only by their cyclic nature
but also by full recovery between acute episodes,
The Recognition and Management of Early Psychosis: A Preventive Approach, ed. Henry J. Jackson and Patrick D. McGorry.
Published by Cambridge University Press. © Cambridge University Press 2009.
Cambridge Books Online © Cambridge University Press, 2009
https://www.cambridge.org/core/terms. https://doi.org/10.1017/CBO9780511576287.014
Downloaded from https://www.cambridge.org/core. Deakin University, Australia (Journals), on 22 May 2018 at 06:53:02, subject to the Cambridge Core terms of use, available at
and globally by a rather favourable outcome. Many
relatively recent publications have come to challenge
this assumption for an important subset of patients
(Coryell et al., 1993; Dion et al., 1988; Harrow et al.,
1990; Tsuang, Woolson & Fleming, 1979; Tohen et al.,
1990a). Various factors have contributed to the devel-
opment of a more realistic view of bipolar disorders.
One of them is the development of a more critical
exploration of outcome (Table 13.1). While most stud-
ies have focused on the observation of the relatively
rapid disappearance of manic symptoms, Tsuang
et al. (1979) were among the first to observe that
24% of patients failed to return to work for up to 30
years after the first manic episode. Similarly, Dion
et al. (1988) observed 44 patients: while 35 (80%)
had no manic symptoms 6 months after hospitaliza-
tion for a manic episode, only 19 (43%) had a job, and
only 9 (21%) worked at their level of premorbid com-
petence. Such a discrepancy between syndromal and
functional outcome has been replicated many times
since (Coryell et al., 1993; Harrow et al., 1990; Keck
et al., 1998; Strakowski et al., 1998; Tohen et al.,
1990a, 2000a). However, it should be mentioned that
most of these studies were conducted in private clin-
ics and, therefore, in selected populations, which do
not include more ill and refractory individuals.
Follow-up studies in broader, more naturalistic and
representative samples are needed to confirm if these
findings are generally applicable.
Very few studies have explored outcome after a
first manic episode. All of them outline a similar
discrepancy between syndromal remission (not meet-
ing criteria for a manic syndrome according to the
Diagnostic and Statistical Manual of Mental
Table 13.1. Outcome after a manic episode in multiple and first-episode mania
Source Setting Results
Multi-episode mania
Tsuang et al., 1979 Field follow-up of 685 patients with
schizophrenia, affective disorders and
non-psychiatric conditions over 30–40 years
24% failed to return to work up to 30 years after manic
episode
Keck et al., 1998 Outcome in 134 bipolar I patients 12 months
after manic or mixed episode
48% syndromic recovery, 26% symptomatic recovery,
24% functional recovery
Dion et al., 1988 Outcome in 44 patients with bipolar I
6 months after manic episode
80% resolution manic syndrome, 43% returned to
professional activity, 21% returned to previous
employment level
Tohen et al. 1990a Outcome 4 years after manic episode Marked discrepancy between symptomatic and
functional outcome remained after 4 years
First-episode mania
Dion et al., 1988 Outcome at 6 months in 14 patients 85% symptomatic remission, 64% returned to
professional activity
Tohen et al., 1992 Outcome at 6 months 85% symptomatic remission, 68% returned to
premorbid functional level
Strakowski et al., 1998 Outcome 12 months after first hospitalization
in 109 patients with an affective psychosis
56% syndromic remission, 35% symptomatic
remission, 35% functional recovery
Tohen et al., 2000a Outcome at 6 months 86% syndromal remission, 33% returned to
premorbid functional level
Tohen et al., 2000b Outcome at 24 months 98% syndromal remission, 40% returned to
premorbid functional level
Conus et al., 2006a Outcome at 12 months 90% syndromal remission, 60% symptomatic
remission, 39% functional recovery
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Disorders, 4th edn (DSM-IV; APA, 1994) criteria),
symptomatic remission (absence of significant symp-
toms) and functional recovery (return to premorbid
level of functioning). For example, Tohen et al.
(2000a), in the frame of the McLean–Harvard First
Episode Project, have explored outcome after a first
manic episode. They found that only 33% of patients
had returned to their previous functional level 6
months after a first manic episode, although 86%
had recovered from the manic syndrome (Tohen
et al., 2000a). At 24 months after the initial manic
episode, while 98% had fully recovered from the
manic syndrome, only 40% met the criteria for func-
tional recovery (Tohen et al., 2000b). These data con-
firmed previous results (Dion et al., 1988; Strakowski
et al., 1998; Tohen et al., 1990b, 1992). A recent anal-
ysis of the outcome of bipolar patients treated for a
first manic episode at the Early Psychosis Prevention
and Intervention Centre (EPPIC) in Melbourne,
Australia, between 1989 and 1997 showed similar
results, in that 90% of patients achieved syndromal
remission at 6 and 12 months but 40% did not meet
symptomatic remission criteria at these points, mainly
because of a host of anxiety and depressive features
(Conus et al., 2006a). Moreover, 66% of patients at 6
months and 61% of patients at 12 months failed to
return to previous levels of functioning. Shorter dura-
tion of untreated psychosis predicted better sympto-
matic outcome, while younger age at intake, family
history of affective disorder, illicit drug use and
absence of functional recovery at 6 months predicted
poorer functional outcome at 12 months (Conus et al.,
2006a). These results are in keeping with data from
Tohen et al. (1990b) and Coryell et al. (1993), who
showed that psychosocial impairment extends to all
areas of functioning.
It should be mentioned, however, that various fac-
tors, such as increased prevalence of substance abuse
and a possible deleterious effect of certain forms of
pharmacological treatment, may have induced a
deterioration in the outcome of mania over the last
century (Zarate et al., 2000). It appears that the pre-
scription of antidepressants has contributed to an
increase in manic relapses (Angst, 1985) and rapid
cycling (Goodwin & Jamison, 1990). Additionally,
excessive prescription of typical neuroleptic drugs
appears to be associated with an increased rate of
depressive episodes (Kukopulos et al., 1980) and
poorer functional outcome (Tohen et al., 1990a). It is
also possible that living in a more complex society,
decreased social support, stigma related to mental
illness and high rates of unemployment in certain
countries hampers return to work. Finally, in some
countries, the process of de-institutionalization, with-
out a corresponding increase in community care, may
have an additional role in reducing access to neces-
sary ongoing care.
Nevertheless, the occurrence of such a poor outcome
after a first manic episode is of significance and estab-
lishes the need for development of new treatment strat-
egies. In 1990, Goodwin and Jamison commented that,
notwithstanding difficulties in distinguishing early
signs of the illness from ‘normal’manifestation of ado-
lescence, attempting to identify these signs was of para-
mount importance considering the potential beneficial
impact of an early start of treatment on later outcome.
Certain treatment principles developed in the frame of
early intervention in psychotic disorders seem to have
the potential to bring us a little closer to this ideal. It is,
therefore, important to determine if targets identified in
early psychosis are relevant to bipolar illness and can
be adapted to the treatment of these disorders.
Are targets for early intervention in
psychotic disorders relevant to bipolar
disorders?
Early intervention in psychosis has two main object-
ives: (1) to decrease the delay to initiation of treat-
ment (through early detection and engagement of
new patients, and if possible detection of high-risk
individuals in order to provide preventive treatment)
and (2) to provide optimal and specific management
for this early phase of the illness. There are some
data to indicate that these objectives may have equal
applicability to bipolar disorders, and that patients
may benefit from treatments based on similar
principles. These arguments are discussed in the
following sections.
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Need for early detection of new cases:
treatment delay in bipolar disorders
The occurrence of a long delay between the onset of
psychotic symptoms and the start of treatment in psycho-
sis, and its implications, have been discussed in detail in
Chs. 8–10. Strategies to overcome this hurdle and their
efficacy have also been described in these chapters.
Various studies on bipolar disorders converge to show
that, on average, there is a very long delay between the
onset of the illness and the time when adequate levels of
care are given (Baethege et al., 2003; Egeland et al., 1987;
Post et al., 2003). For example, Post et al. (2003, p. 317)
reported an ‘average of 10 years between first symptoms
meeting diagnostic threshold and first treatment’, and
Baethege et al. (2003) found an average mean latency of
9.3 years between first medical contact for the mood
disorder and the commencement of treatment with a
mood stabilizer.
Various factors can be responsible for such a delay in
diagnosing bipolar disorders. First, the index episode of
illness is depressive in the majority of patients, and, as a
consequence, the most common initial diagnosis is of
unipolar depression (Lish et al., 1994). Second, because
of the often atypical clinical presentation of mania (high
rate ofmixed episodes, presence of irritability and flight of
ideas rather than the typical euphoria and grandiosity,
high rate of psychotic symptoms and comorbidities),
many professionals fail to identify mania in adolescents
and young adults (Joyce, 1984). Third, hypomania is often
pleasant and not associated with impairment and, there-
fore, notmentioned by patients (Berk et al., 2006). Fourth,
the presence of substance-abuse comorbiditymay deflect
diagnostic attention (Berk et al., 2006). Finally, delay is
sometimes not linked to failed diagnosis but rather to
patients’ reluctance to ask for mental healthcare. For
example, ten Have et al. (2002), in the Netherlands
Mental Health Survey and Incidence Study on bipolar
disorders in the Dutch general population, observed
that only 4 out of 10 patients with bipolar disorder had
contacted mental heath services in order to receive care.
Moreover, a large percentage of those who established
contact with mental health services did not present com-
plaints related to their bipolar disorder, an observation
already made by Lish et al. (1994).
Case vignette
John was 14 when his teachers began to complain about his
disruptive behaviour. He had started skipping school and
smoking cannabis and his parents noticed periods of irritabil-
ity when he was going out all night with his friends, and others
where he withdrew and avoided contact. When he was 17, he
was admitted for the first time to hospital after a week of
sleepless nights where he was smoking a lot, listening to loud
music and speaking to himself in his room. He was very
agitated and convinced his mind was controlled by aliens
who wanted him to fulfil a special mission. He was diagnosed
with a first episode of psychosis, recovered quickly from his
psychotic symptoms and was discharged with a neuroleptic
treatment that he stopped a week after discharge. Between 17
and 21 years of age, he was admitted four times with a similar
clinical presentation and was diagnosed with schizophrenia.
During his sixth admission when he was 22, clinicians realized
that the successive periods of irritability and withdrawal cor-
responded to manic and depressive phases of a bipolar disor-
der; a mood stabilizer was introduced, and since then John has
begun to progress towards stability.
Consequences of delayed diagnosis
First, some authors have suggested that there may be a
reduction in the effect of lithium with increasing delay
between onset of the disorder and the instigation of
medication (Post et al., 2003). This issue is still debated,
however, since other authors have failed to find such an
association (Baethege et al., 2003; Baldessarini, Tondo &
Hennen, 2003). Whatever the case may be, most
authors agree that delay in treatment is linked to poorer
social adjustment, a higher number of hospitalizations
(Goldberg & Ernst, 2002), increased risk of suicide,
development of comorbidities, forensic complications
and global impairment of the capacity to face develop-
mental tasks (Conus & McGorry, 2002). Second,
increasing numbers of episodes are also associated
with a shortening of the frequency of the cycle (Angst,
Felder & Lohmeyer, 1980; Roy-Byrne et al., 1985; Zis
et al., 1980). This may be linked to Post’s (1992) neuro-
sensitization model, which suggests that an increasing
number of relapses produces not only acute modifica-
tions but also more permanent alterations in neuronal
activity, possibly transduced at the level of gene
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expression. These alterations, in turn, might induce a
higher tendency to relapse, and possibly a poorer
response to medication. Third, delayed identification
of bipolar disorder and misdiagnosis with unipolar
depression can lead to the prescription of antidepres-
sant therapy, which can induce rapid cycling, mania,
mixed states and treatment resistance (Ghaemi, Ko &
Goodwin, 2002). Fourth, misdiagnosis may also lead to
inadequate psychoeducation, inappropriate medica-
tion regimens (which, in turn, may have a negative
effect on outcome) and rejection from clinicians when
symptoms are mislabelled as behavioural issues.
Finally, untreated illness may interfere with the attain-
ment of age-specific social, psychological and educa-
tional developmental goals (Macneil, 2004).
Optimal treatment of the first episode:
are there specific treatment guidelines
for the early phase of bipolar disorders?
As Malla and Norman (2001) pointed out, early inter-
vention is not only about intervening early; it should
also involve the development of specific treatment
strategies. Recent developments in early intervention
strategies have revealed the need for specific pharma-
cological guidelines. For example, it has been shown
that lower doses of antipsychotic medication have sim-
ilar efficacy but a much lower risk of side effects in early
psychosis than doses usually prescribed to patients
with more chronic disorders (Malla & Norman, 2001;
Remington, Kapur & Zipursky, 1998). Additionally, in
order to improve outcome, first-episode patients need
specific psychological treatment programmes geared
towards not only the phase of illness but also the
stage of psychosocial development and its associated
needs and difficulties (Macneil, 2004).
Current guidelines
Current treatment strategies for bipolar disorders have
been developed mainly on the basis of studies con-
ducted in populations of patients with chronic disorder
(APA, 2002). Unlike in other medical disciplines such as
oncology, psychiatry generally does not use staging
models to delineate phase-specific treatment needs.
To our knowledge, none of the official guidelines for
treatment of bipolar disorders makes mention of spe-
cific strategies for the early phase of the illness, neither
concerning medication nor regarding psychological
approaches (Conus, Berk & McGorry, 2006b). The
only guideline elements that can be derived from the
most recent version of the Practice Guidelines for
the Treatment of Patients with Bipolar Disorder, pub-
lished by the American Psychiatric Association (APA,
2002) and that can apply to the early phase of bipolar
disorders can be summarized as follows.
1. Mood stabilizers (lithium or valproate) should be
used during the acute manic phase and continued
for at least 6 months after a single manic episode, or
18 months in children and adolescents.
2. Antipsychotic medication should be used in associ-
ation with mood stabilizers according to the severity
of the episode and/or the presence of psychotic
symptoms.
3. When entering the maintenance phase of the treat-
ment, need for ongoing antipsychotic medication
should be reassessed. Although atypical antipsy-
chotic drugs are sometimes considered for mainten-
ance therapy, definitive evidence that their efficacy
as maintenance treatment is comparable to that of
lithium or valproate is still missing.
It is worth noting that this last recommendation is likely
to change given the recent publication of evidence that
atypicals indeed do have maintenance efficacy. For
example, olanzapine has been shown to have compar-
able efficacy to lithium (Tohen et al., 2005), and has
been reported to be superior to placebo in prevention
ofmania, depression and overall relapse in randomised
designs (Tohen et al., 2003a,b, 2004).
In addition, a few recent publications have proposed
guidelines for the treatment of first-episode psychosis
but some of the proposed strategies still need to be
studied in the frame of randomized controlled trials
(Lambert et al., 2003; National Early Psychosis Project,
1998; Royal Australian and New Zealand College of
Psychiatrists, 2005; International Early Psychosis
Association Writing Group, 2005). The guidelines
published by the Canadian Network for Mood and
Anxiety Treatments (Yatham et al., 2005) provide more
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up-to-date information regarding issues such as the role
of atypical antipsychotic medication in the acute and
maintenance phases. Nevertheless, they also fail to
address the issues specifically related to the early phase
of the disorder.
Current practice
These limited guidelines do not seem to reflect current
practice for the treatment of first-episode mania, princi-
pally regarding the use of antipsychotic medication.
Despite the availability of benzodiazepines to help to
control agitation in the acute phase, and regardless of
the above-mentioned recommendation that antipsy-
chotic drugs should be used only during acute manic
phases with psychotic features, or in particularly severe
manic ormixed episodes, antipsychotic drugs remain the
most commonly prescribed adjunctive treatment for
mania (Conus & McGorry, 2002). Zarate et al. (2000)
found that patients with first-episode mania were as
likely as those with first-episode non-affective psychosis
to receive antipsychotic drugs, although usually at lower
dosage. Moreover, they found that 77% of these patients
with first-episode mania received antipsychotic medica-
tion at discharge and 25% were still receiving it at the 6-
month follow-up. In populations with chronic disorder
and 6 months after hospitalization for a manic episode,
68% to 95% of patients who have been prescribed anti-
psychotic drugs are still taking them, and usage in up to
67% has been observed during the maintenance phase
(Sernyak et al., 1994; Verdoux et al., 1996). This is a
matter of concern for various reasons. First, bipolar
patients have a high susceptibility to tardive dyskinesia
if they take typical antipsychotic drugs (Keck, McElroy &
Strakowski, 2000). Second, if these drugs rather than
benzodiazepines are used for acute control of behaviour,
they tend to be prescribed at high dosages and this can
induce extrapyramidal syndromes and lead to prolonged
alienation of patients from treatment. Additionally, Craig
et al. (2004) found that patients who were prescribed
typical antipsychotic medication ended up with poorer
scores on the Global Assessment of Functioning (APA,
1994) at outcome and spent less time in remission. Zarate
et al. (2000) also found that prolonged prescription of
typical neuroleptic drugs after remission of mania had a
detrimental effect (increased risk of side effects, dyspho-
ria, depressive symptoms, shorter time to depressive
relapse). Atypical antipsychotic agents constitute a prom-
ising alternative to typical neuroleptics for use in acute
bipolar mania (Mensink & Sloof, 2004). Their
mood-stabilizing capacities still need to be studied
(Mahli et al., 2005). Unfortunately, atypical antipsychotic
drugs also induce side effects, such as somnolence,
hyperprolactinaemia, osteoporosis, dyslipidaemia, weight
gain and diabetes, and even extrapyramidal symptoms
(Mahli et al., 2005).
Guidelines for prescription of mood stabilizers
Because of the high risk of relapse after a first manic
episode and the deleterious effect of multiple episodes
on outcome, current guidelines suggest maintenance
therapy should be proposed after a first manic episode
(Yatham et al., 2005). Additionally, the notion that mood
stabilizers have a primary neuroprotective function is
gaining currency (Hennion et al., 2002). There is ample
neuroimaging data regarding structural changes in bipo-
lar disorder (Monkul, Mahli & Soares, 2005), and recent
data suggest that atypical agents prevent structural
changes in first-episode psychosis (Lieberman et al.,
2005). Similarly, there are data suggesting that lithium
and valproate can prevent tissue loss in the amygdala in
paediatric bipolar disorders (Chang et al., 2005). If fur-
ther research confirms these findings, it could strongly
support the idea of early initiation of maintenance ther-
apy. However, considering the difficulties most young
patients have accepting a diagnosis of bipolar disorder
after a first manic episode, the poor adherence rates to
lithium in first-episode cohorts and the risk of a rebound
episode on abrupt discontinuation, this guideline is
often hard to follow in clinical practice.
Treatment adherence
Finally, another dimension of pharmacological treat-
ment, namely adherence to prescribed medication,
deserves specific attention. Non-adherence to treatment
is known to be an important problem in any medical or
psychiatric condition and has been identified as one of
the major risk factors for relapse in bipolar disorders.
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Basco and Rush (1995) showed that the rate of non-
adherence with mood stabilizers was close to 50%. In a
cohort of 101 patients hospitalized for acutemania, Keck
et al. (1996) demonstrated that 64 (64%) were non-
adherent to their medication in the month prior to
admission. They also found that treatment adherence
was associated with higher rates of recovery and more
rapid recovery (Keck et al., 1998). In first-episode
patients, the rate of non-adherence seems to be even
higher and is reported by some authors to be as high as
57% (Cochran, 1984). Among the 83 bipolar patients in a
cohort of 109 patients with a first episode of an affective
disorder, Strakowski et al. (1998) reported that 41% were
fully adherent, 26% partially and 33% totally non-
adherent. Craig et al. (2004) found that 43% of patients
were non-adherent to mood stabilizers at 6 months.
These numbers might be explained by various factors.
First, denial is an associated feature of the illness. It is
common for individuals to have a number of episodes
before accepting the implications of the recurrent nature
of the illness. Furthermore, lifestyle change involved in
taking prophylactic medication represents a major chal-
lenge, especially for young people. This underlines the
need to develop psychosocial interventions aimed at the
specific needs of this group of individuals (Macneil,
2004). The impact of non-adherence on outcome of
first-episode mania has not been well studied.
Strakowski et al. (1998) found that syndromal recovery
was more likely to occur for patients with full adherence
than for those with partial adherence. The impact of total
non-adherence is more difficult to assess because
non-adherent patients tend to drop out of research
studies altogether. Moreover, non-adherence rarely
occurs in isolation and is often combined with other
poor prognostic factors such as substance abuse, and
might then have an indirect as well as a direct effect on
outcome. It is, however, possible that adherence may be
a marker of other behaviours or illness characteristics
modulating outcome.
Case vignette
Amanda was admitted for the first time when she was 19 years
old. She had become progressively agitated and restless over
the last month, and hardly slept more than 3 hours a night
during the few days preceding admission. She was spending
most evenings going out partying without experiencing any
feelings of tiredness. On the day of admission, she got into an
argument in a shop after she had tried on clothes for more
than 2 hours and pretended to leave with various items with-
out paying. On the ward she was over-familiar with the nursing
staff, disinhibited and irritable, and her thoughts were accel-
erated. After long negotiations, she finally accepted medica-
tion and was given benzodiazepine first and then sodium
valproate. While manic symptoms decreased, she agreed she
had gotten carried away at some point but rejected the idea of
having had a manic episode. She said she was feeling better
than ever and that she had finally overcome her shyness. After
discharge, she rapidly discontinued medication, and told her
case manager that it made her feel depressed and tired. She
also said she missed the time when she was feeling high, and
she minimized her disturbed behaviour before admission.
Defining targets for early intervention
in bipolar disorders
Based on the previous two sections, it seems clear that
early intervention strategies are justified in the treat-
ment of bipolar disorders. However, as mentioned, one
of the main challenges in the development of such
strategies is to formulate a better definition of the vari-
ous stages of the disorder, which leads from a vulner-
ability status to the initial onset-phase and then to the
full-blown disorder. The task is made difficult by the
nature of the disorder and its cyclical aspects. First,
the initial manifestation of bipolar disorders can take
many shapes, ranging most commonly from depressive
episodes of varying intensity to mania of abrupt onset,
both of which can be very hard to diagnose (Berk et al.,
2006). In many other cases, onset may be much less
clear-cut and manifest as ill-defined mood disturban-
ces. Even though the sensitivity of such symptoms may
be significant, their specificity is very low, and they may
be very hard to distinguish frommanifestations of early
adolescence, normal reactions to life events, or early
signs of other disorders.
Therefore, one of the main challenges is to diagnose
these initial manifestations properly in order to deter-
mine which one will eventually lead towards bipolar
disorder and, thus, to initiate proper treatment as soon
Chapter 13: Preventive strategies in bipolar disorders 229
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as possible. In this context it may prove useful to apply a
combined strategy: (1) to develop a better character-
ization of the signature of bipolar depression, allowing
prospective identification of bipolarity in individuals
presenting with depression; (2) to gather more exten-
sive knowledge about initial manic manifestations of
the disorder; and (3) to explore and define the more
progressive forms of onset, which by analogy with early
psychosis could be defined as the ‘initial prodrome’ to
bipolar disorder.
Bipolar depression
As discussed above, depression is the most common
type of onset in bipolar I patients (Perugi et al., 2000).
Additionally, in bipolar disorder, the bulk of morbidity
is in the depressive phase of the disorder. Finally, the
ratio of depressive to manic episodes in bipolar I dis-
order is 3:1, whereas in bipolar II disorder the ratio of
depression to hypomania is 47:1 (Judd et al., 2002).
This creates a scenario where young people with
developing bipolar disorder present with depression
and are inevitably at risk of being misdiagnosed as
unipolar. This is a concern, considering that antide-
pressants can induce mania, mixed states and rapid
cycling in susceptible individuals; that antidepressant-
induced manias are more likely to be dysphoric than
euphoric (Berk & Dodd, 2005); that mania in young
people is indeed more likely to be dysphoric
(Wozniak, Biederman & Richards., 2001); and finally,
that suicidal risk is disproportionately high in mixed
states (Berk & Dodd, 2005). For these reasons, the
development of strategies allowing an accurate and
early diagnosis of bipolarity in depressed young indi-
viduals is critical and is an important target for early
intervention.
First-episode mania
A major reason for latency between onset and treat-
ment in bipolar disorders is the failure to identify mania
in young patients, which can be explained by various
factors. First, the clinical presentation of mania is
frequently atypical in adolescents and young adults,
with high rates of mixed episodes, as evidenced by
irritability and increase in energy and flight of ideas
rather than euphoria and grandiosity (Akiskal et al.,
2003; Wozniak et al., 2001). Second, mild mania is
uncommonly a source of distress and, therefore, sel-
dom a focus of clinical attention. Third, disruptive
behaviour in mania can overlap phenomenologically
with personality disorders: symptoms and diagnosis
can easily be mistaken for cluster B personality traits
and disorders in patients with recurrent and
long-standing behavioural disturbances, unstable per-
sonal relationships and periodic affective symptoms
(Tryer & Brittlebank, 1993). Akiskal (1981) showed
that secondary personality dysfunction can develop in
the context of prolonged affective disturbances and can
be confused with personality disorder. Fourth, there is
also a high rate of comorbidity and overlap with mani-
festations of other disorders, such as attention deficit
hyperactivity disorder, anxiety, substance-use disorder
and antisocial behaviour (Wozniak et al., 2001). Finally,
younger patients present with a higher rate of psychotic
symptoms (Joyce, 1984), more often of a mood-
incongruent nature (McGlashan, 1988). For example,
in a sample of 108 patients with first-episode psychotic
mania treated at EPPIC between 1987 and 1995, Conus
et al. (2004) found high rates of mood-incongruent
psychotic symptoms, persecutory delusions and
Schneiderian symptoms, not only in those with a diag-
nosis of schizoaffective disorder (100%, 86%, and 81%,
respectively) but also in those with a diagnosis of bipo-
lar disorder (74%, 69%, and 59%, respectively). Such a
presentation leads to a high rate of misdiagnosis, most
often with schizophrenia, but also with conduct disor-
ders, attention deficit hyperactivity disorder and anti-
social or borderline personality disorders. Clinicians
need to be more aware of these elements in order to
be able to consider a diagnosis of mania, even if the
clinical presentation is not dominated by euphoria and
grandiosity; this, in turn, may allow an earlier andmore
accurate identification of bipolar disorders.
Initial prodrome to bipolar disorder
As mentioned above, in many cases it appears that
bipolar disorders develop in a progressive manner. As
a first step, it might prove useful to apply the concepts
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of ‘prodrome’ and ‘onset’ to bipolar disorders as they
have been used for psychosis in general and schizo-
phrenia in particular. The ‘prodrome’ can be defined as
the period of disturbance that represents a deviation
from a person’s previous experience and behaviour,
prior to the development of the threshold features of a
disorder. By comparison, the ‘onset’ can be more diffi-
cult to define in bipolar spectrum disorders. For exam-
ple, it might become clear only much later and
retrospectively that an initial depressive episode was
actually the first manifestation of a bipolar I disorder.
As a first approach, it might prove useful to draw an
analogy between first-episode mania and first-episode
psychosis. The first psychotic episodemust occur for the
clinician to make the diagnosis of a psychotic disorder
(and is absolutely necessary, for example, for schizo-
phrenia to be diagnosed) and gives coherence to earlier
manifestations of the illness once they can be put in the
context of the prodromal phase. Similarly, the firstmanic
episodemarks the diagnosis of a bipolar I disorder.What
happens during the pre-manic phase – episodes of sub-
threshold or threshold depression, hypomania or anxi-
ety syndromes, for example – could be considered as the
initial prodrome to bipolar I disorders and become a key
target for early intervention. However, a key challenge is
that, as in prodromal schizophrenia, potential early
symptoms of bipolar disorder such as depression and
anxiety are both widespread and of low specificity.
Additionally, they are more likely to follow an intermit-
tent, rather than a continuous, pattern. Mild mania,
while specific, is ego-syntonic, rarely distressing and
consequently seldom reported. Moreover, such defini-
tions have limitations and are difficult to apply to other
disorders of the bipolar spectrum, such as bipolar II
disorders. Nevertheless, they might allow the explora-
tion of the initial phase of the illness and be further
refined and adapted at a second stage.
Where do we go from here?
In summary, treatment of the early phase of bipolar
disorders currently lacks specificity, and most pub-
lished guidelines fail to differentiate treatment strat-
egies early in the course from those recommended for
later stages. The important issues of inaccurate and
delayed identification of the disorder, delayed prescrip-
tion of mood stabilizers, unclear ideal duration of
mood-stabilizer treatment, high use of antipsychotic
medication and, finally, poor adherence to treatment
have been described above. Additionally, there are
specific psychological and social issues associated
with the onset phase of the disorder that are not specif-
ically addressed by currently available psychological
interventions. All these elements suggest there is an
urgent need for research and development in early
intervention in bipolar disorders. Various strategies
that could be applied to face this challenge within the
broader framework of early intervention strategies in
psychiatry are discussed below.
Earlier identification of bipolar disorders
Earlier identification of the disorder would allow psy-
chological and pharmacological treatment to be com-
menced sooner, with the potential to reduce the
neurobiological and psychosocial collateral damage
caused by prolonged duration of untreated illness.
Additionally, medication could be introduced in a
phase where it may be more efficacious. Two strategies
might have an impact on delayed identification of bipo-
lar disorders: improved identification of first-episode
mania and of bipolar depression.
Improved identification of first-episode
mania
Mania often has an atypical mixed or dysphoric pre-
sentation during adolescence and early adulthood.
Clinicians should be more aware of this problem, and
replication and extension of studies focusing on the
particular clinical presentation of first-episode mania
are useful in this regard. However, such studies aiming
at identifying and refining the characterization of dis-
crete syndromes have their limitations. As mentioned
by McGorry (1995a), current categorical classifications
for mental disorders do not fit well with the clinical
presentation of initial psychotic disorders; this certainly
also applies to affective psychoses and bipolar dis-
orders. It may, therefore, prove useful to develop
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diagnostic approaches based on a dimensional con-
cept. In this frame, the ‘affective dimension’ of a clinical
presentation may constitute a valid and useful addi-
tional target for early intervention.
Identification of bipolar depression
There is currently limited knowledge regarding the char-
acteristics of depressive episodes that might presage the
future development of bipolar illness. Strober and
Carlson (1982) examined a cohort of 60 adolescents
with major depression and found that the presence of
mood-congruent psychotic features, psychomotor retar-
dation, rapid onset and pharmacologically induced
hypomania was associated with a higher risk of devel-
oping bipolar illness. More recently, Berk et al. (2004)
reviewed the literature relevant to this issue and pointed
out the following features of bipolar depression: early
age of onset, abrupt onset/offset, psychomotor retarda-
tion (altered emotional reactivity, delay in verbal
response, slowed movements), melancholic symptoms
(worthlessness, unvarying mood, marked anhedonia),
atypical depressive symptoms (hypersomnia, hyperpha-
gia, leaden paralysis) and other features such as irrita-
bility, mixed states, lability and high level of recurrence.
A new Bipolar Depression Rating Scale has been devel-
oped that should contribute to resolving this issue (Berk
et al., 2007). Screening instruments for hypomania such
as the Mood Disorder Questionnaire (Hirschfeld et al.,
2003a) would also be a valuable additional component
to routine care to detect potential bipolarity in young
individuals presenting with depressive symptoms.
Identification of the initial prodrome
to bipolar disorders
While an important body of literature has been pub-
lished on the warning signs of manic relapses, the
‘initial prodrome’ to bipolar disorders has received
little attention. Various approaches can be proposed
to explore this phase of the illness. Akiskal et al.
(1985) prospectively followed 68 juvenile offspring or
siblings of bipolar patients with mood symptoms. They
observed an often insidious onset of bipolar disorder in
late childhood, adolescence or early adulthood, with
relatively minor oscillations in mood that were mainly
depressive in nature. It could be argued, however, that
the restriction of the study to offspring of bipolar
patients might limit the relevance of the findings to be
only applicable for patients with a family history of
bipolar disorder, which is not true for all bipolar
patients. The most systematic and detailed study of
the initial prodrome to bipolar disorder to date comes
from Egeland et al. (2000), who as part of a broader
Amish study examined medical histories of 58 bipolar I
patients. They were able to identify a range of symp-
toms and behaviours predating the onset of illness:
episodic changes in mood (depressed mood 53%,
anger dyscontrol 38%, irritable mood 33%) and energy
(increased energy 47%, decreased energy 38%) were
the most consistently reported. These were followed
by bold/intrusive behaviours (29%), excessive behav-
iours (28%), conduct problems (28%), decreased sleep
(26%), crying (26%) and oversensitivity (24%). The
strengths of this study are its inclusion only of patients
formally diagnosed with bipolar disorder, and its use of
data spontaneously provided during the early phase of
illness. However, it is limited by its reliance on file data
rather than on a standardized interview, and by the fact
that social history was provided by informants rather
than by the patients themselves. This may have led to
an overemphasis on observable behavioural changes
and neglect of depression or more subjective aspects of
prodrome and onset. Additionally, the study was con-
ducted within an Amish population; young people who
develop bipolar disorders and live in more standard
conditions are highly likely to have an added smoke-
screen of substance abuse added into the clinical pic-
ture, making early diagnosis even more difficult. A
study is currently underway at EPPIC that aims to
assess retrospectively the 12 months preceding a first
manic episode in a cohort with a first episode of bipolar
mania, in order to identify possible clinical markers of
an at-risk mental state (Conus et al., 2006c).
In contrast to these retrospective studies, Thompson
et al. (2003) have provided prospectively collected data
about the development of manic episodes in three
patients who developed bipolar I or II disorder during
their treatment in a clinic specializing in patients at
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ultra high risk of developing psychosis (Yung et al.,
2003). A review of the case descriptions reveals that all
three patients presented with an initial depressive epi-
sode and reported some degree of anxiety and paranoia
prior to their inclusion in the clinic. Other symptoms
that either emerged or were evident during the three
patients’ 12 months of treatment included mood
swings (in two), racing thoughts (in two), increased
activity/energy (in two), decreased energy/tiredness
(in two), disturbed sleep (in two), distractibility/diffi-
culty concentrating (in two), and perceptual changes
(in two). A range of comorbid diagnoses were also
present. These symptoms are generally in keeping
with those of the retrospective reports (Egeland et al.,
2000) but it is important to note that there were no
specific prodromal features that clearly distinguished
patients who developed bipolar disorder from those
who developed other psychoses such as schizophrenia.
Other limitations of this study include its very small
sample size and its focus on early psychosis rather
than exclusively on bipolar disorders, which implies
the use of assessment tools that may not have been
specific enough to capture various aspects of the
pre-manic mood prodrome.
It is important to note that this approach, as well as
the methods used in studies mentioned above, have
important limitations; for example, none of them used
a matched control group of participants who do not go
on to develop bipolar disorder, and there are problems
with retrospective recall as it introduces subjective
bias and also relies upon the patient’s memory.
Additionally, Bellivier et al. (2003) demonstrated in a
consecutive series of 368 patients that it is possible to
differentiate, based on the age of onset, three sub-
groups of bipolar disorders: (1) an early age of onset
group (mean age 17.4 years), (2) those with a medium
age of onset (mean age 25.1 years), and (3) those with
late age of onset (mean age 40.4 years). This may fur-
ther complicate the exploration of the prodromal
phase, since it is likely that each of these subgroups
go through distinct and specific prodromal phases. For
example, it has been shown that the ‘early presentation’
category tends to be associated with early comorbid
forms of presentation, higher levels of functional
impairments and more frequent psychotic symptoms
(Carlson, Bromet & Sievers, 2000). However, despite
these difficulties and limitations, these works open a
new field of research and pave the way for more sophis-
ticated research protocols. Once potential high-risk
profile(s) for bipolar disorders can be defined, the
next step would be to explore their validity and specif-
icity in the context of larger prospective high-risk
studies.
Development of specific guidelines for
the treatment of the early phase of bipolar
disorders
Pharmacological treatment
Pharmacological treatment of the early phase of bipolar
disorders needs to be more extensively studied in order
to develop phase-specific guidelines. Each phase defined
abovemay then constitute a specific stage of the disorder
where distinct treatment strategies would apply.
The identification of patients going through a pro-
dromal phasewould allow the study of biological events
occurring during this critical phase (e.g. modifications
of brain structure or gene expression) or the identifica-
tion of psychosocial factors that might be linked to the
emergence and development of the disorder. This, in
turn, could lead to the development of potential pre-
ventive strategies such as neuroprotective agents, psy-
chosocial interventions or primary prevention of
secondary substance-use disorder (Thompson et al.,
2003). If identification of bipolar depression can be
improved, the issue of initiation of mood stabilizers in
young people with a suspected bipolar basis to their
depression could be explored. This would contribute to
avoidance of the risk of development of mixed or dys-
phoric mania and consequent suicidal tendencies
under antidepressant treatment. No such trials have
been conducted though they are strongly needed
(Baldessarini et al., 2003; Geller et al., 2004). In first-
episode mania, it would be useful to compare the effi-
cacy and effectiveness of mood stabilizers as well as to
define the ideal duration of prophylaxis after a first
manic episode. Studies are needed on antipsychotic
treatment (1) to define the need for, and the optimal
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duration of, antipsychotic treatment both in psychotic
and non-psychotic mania; (2) to compare typical and
atypical antipsychotic drugs in terms of safety as well as
efficacy; and (3) to compare the efficacy and effective-
ness of various atypical antipsychotic drugs in both the
acute and the maintenance phases. Regarding this last
issue, a file audit study recently conducted at EPPIC
explored response to treatment in a non-randomized
non-controlled naturalistic setting and showed that
olanzapine had a higher efficacy than risperidone in
first-episode affective (mainly manic) psychoses, lead-
ing to lower scores on the Clinical Global Impression
scale (Guy, 1976) at the end of the trial, a higher rate of
global improvement on this scale and a higher rate of
remission of positive symptoms (Lambert et al., 2005).
Similarly, the comparative efficacy and effectiveness of
mood stabilizers in this population has not been docu-
mented. Finally, it is necessary to examine whether
atypical agents or traditional mood stabilizers have
neuroprotective properties in first-episode patients.
The confirmation of the capacity of such agents to
prevent the neurostructural, neurocognitive and func-
tional consequences of illness would indeed constitute
a critical element in helping to define when, and for
how long, they should be prescribed.
Psychological approaches
It must be emphasized that the treatment of the early
phase of bipolar disorders should involve considerably
more than providing medication. Indeed, there has
been recognition of this by a number of organizations
including the British Association of Psychopharmacology,
the World Federation of Biological Psychiatry and the
American Psychiatric Association (Jones, Sellwood &
McGovern, 2005). The 1990 US National Institute of
Mental Heath (NIMH) report (Prien & Potter, 1990,
p. 149) succinctly acknowledged ‘… it is clear that
pharmacotherapy alone does not meet the needs of
many bipolar patients’.
In recent years, there has been a growth in research
on psychological interventions for bipolar disorder.
Specifically, recent reviews have found that individual
cognitive–behavioural therapy can have an impact
on the symptoms of bipolar disorder, medication
adherence, social functioning and likelihood of relapse
(Gonzalez-Pinto et al., 2004; Huxley, Parikh &
Baldessarini, 2000; Jones, 2004; Scott & Gutierrez,
2004). Although none of these studies was designed
specifically for a first-episode population, an emphasis
on the importance of early intervention is supported by
the finding by Scott et al. (2006) in the largest random-
ized controlled trial of cognitive–behavioural therapy
for bipolar disorder to date, which indicated that this
approach was more effective for people who had fewer
episodes.
However, the population with first-episode bipolar
disorder can provide a clinician with a number of chal-
lenges as patients often present with poor insight and
high rates of comorbidity with alcohol (Conus &
McGorry, 2002) and substance use (Ernst & Goldberg,
2004). Therefore, the clinician may face potential
engagement difficulties with a first-episode population,
which should be addressed before commencing a psy-
chological intervention. It may be that a focus on the
person’s explanatory model of their situation, assist-
ance with practical issues (including addressing
accommodation, financial and legal issues), and joint
goal setting may be required and may assist with
enhancing engagement.
Awareness of developmental issues is also essential
when providing psychological interventions for people
with first-episode bipolar disorder, given that most
people develop the disorder in their late teens and
early twenties (Burke et al. 1990; Hirschfeld, Lewis &
Vornik, 2003b; Lish et al., 1994). Specifically, the clin-
ician should attend to the impact of the disorder on the
person’s developmental trajectory, including their abil-
ity to develop independence, and should ‘pitch’ infor-
mation or therapeutic interventions appropriately to
the person’s cognitive and emotional level, and involve
family members, who may play a considerable role in
the person’s life in the treatment process.
It is now commonly accepted that psychoeducation
should be regarded as a key element of good practice
in the treatment of bipolar disorders. As Colom et al.
(2003) showed, psychoeducation prevents relapses and
hospital admission in euthymic bipolar patients.
Psychoeducation as it is conducted today in bipolar
disorder integrates the following elements: early
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detection of the illness (Perry et al., 1999), promotion of
regular and adequate lifestyles (Frank et al., 1999), the
improvement of therapeutic adherence (Scott &
Tacchi, 2002) and treatment of symptoms and the res-
olution of problems (Lam et al., 2003). All of these
elements should be integrated in psychoeducation pro-
grammes for bipolar disorders.
However, standardized psychoeducation may
require modification for working with a first-episode
population. Many individuals with first-episode bipolar
disorder may be unwilling to accept their diagnosis,
and simply distributing pre-packaged handoutmaterial
without an understanding of the person’s level of
insight or an explanatory model may at best be ineffect-
ive and at worst damage engagement and the thera-
peutic relationship, increase likelihood of dropout or
lead to catastrophization and over-identification with
the disorder. Therefore, it appears that psychoeduca-
tion should occur with a strong awareness of what
McGorry (1995b, p. 320) referred to as the ‘psychoedu-
cational needs’ of the person, and should involve ‘… the
provision of the right kind of information, provided
flexibly and sensitively to each individual …’.
In a cohort of 87 patients with first-episode bipolar
mania, 35 (41%) failed to reach symptomatic remission
after 12 months despite a generally good syndromic
recovery, and only 34 (39%) returned to their premor-
bid level of functioning (Conus et al., 2006a). Patients
who remained symptomatic suffered mainly from anxi-
ety, particularly social phobia and restriction of social
interactions. Additionally, a significant proportion of
patients abused illicit substances and failed to adhere
to medication.
Emphasis on functional recovery needs to address
these comorbid difficulties andmay also involve practical
assistance around social and vocational functioning,
including liaison with employment, educational and vol-
untary services to assist people in returning to their level
of premorbid functioning. Planning for returning to work
or study, including managing anxiety, discussion around
how the person will explain their absence and identifying
potential stressors, can be valuable. In addition, encour-
aging return to regular sleep and activity schedules can
be important prior to recommencing work or study, as
these are often disrupted by the disorder.
Relapse-prevention work with people in the first epi-
sode can be challenging, as lack of insight, denial and
minimization may be more likely in this population,
than in a population who have experienced multiple
episodes. Rather than simple symptom monitoring,
which can create unnecessary hypervigilance and
‘false positives’ following a first episode in individuals
and their families, attending to themeaning associated
with risk of relapse can be a valuable intervention.
Specifically, identifying the person’s beliefs about like-
lihood of relapse, their perceived control over this
and the anticipated outcome should a relapse occur
can be an extremely useful focus for psychological
intervention.
In summary, psychological interventions with
first-episode bipolar disorder can include:
 a strong emphasis on engagement and the import-
ance of developing a positive therapeutic relation-
ship, which can be challenging in the first episode
 awareness of the impact of developmental issues on
the presentation of the disorder and its treatment
 involving family members where appropriate, given
the likely importance of family members for a
first-episode population
 psychoeducation, provided with awareness of its
potential impact on the person’s sense of self and
understanding of the potentially protective nature of
denial, and managing this sensitively
 relapse prevention, including discussion of associ-
ated affect and the person’s beliefs around the like-
lihood and potential impact of relapse
 emphasis on functional recovery, given that this has
been largely neglected to date.
Conclusions
While confirming the dearth of early-intervention strat-
egies and the absence of guidelines for the treatment of
the first stages of bipolar disorders, the arguments
developed in this chapter show that the principles
guiding the approach of early psychosis may also be
relevant to bipolar disorders. Specific targets can be
identified that need to be defined more clearly in
order to provide a framework for future research trials.
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Once initiated, this domain of research would open the
door to numerous other areas of investigation (brain
structure, cognition, functional neurochemistry and
neuroprotection) that could both improve our under-
standing of the nature of bipolar disorders and lead to
the development of new treatment approaches of
higher efficacy.
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